72802-41-6Relevant articles and documents
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer
Lin, Shu-Yu,Chang Hsu, Yung,Peng, Yi-Hui,Ke, Yi-Yu,Lin, Wen-Hsing,Sun, Hsu-Yi,Shiao, Hui-Yi,Kuo, Fu-Ming,Chen, Pei-Yi,Lien, Tzu-Wen,Chen, Chun-Hwa,Chu, Chang-Ying,Wang, Sing-Yi,Yeh, Kai-Chia,Chen, Ching-Ping,Hsu, Tsu-An,Wu, Su-Ying,Yeh, Teng-Kuang,Chen, Chiung-Tong,Hsieh, Hsing-Pang
supporting information, p. 10108 - 10123 (2019/11/29)
Epidermal growth factor receptor (EGFR)-targeted therapy in non-small cell lung cancer represents a breakthrough in the field of precision medicine. Previously, we have identified a lead compound, furanopyrimidine 2, which contains a (S)-2-phenylglycinol
Regioselective three-component synthesis of 1,2-diarylindoles from cyclohexanones, α-hydroxyketones and anilines under transition-metal-free conditions
Li, Cheng,Xie, Yanjun,Xiao, Fuhong,Huang, Huawen,Deng, Guo-Jun
supporting information, p. 4079 - 4082 (2019/04/25)
A facile method for the one-pot synthesis of 1,2-diarylindoles under transition-metal-free conditions is described. Cyclohexanones were used as the aryl sources via the dehydrogenative aromatization process. One C-C and two C-N bonds were selectively formed via a domino reaction. This protocol provides a convenient approach for the construction of valuable bioactive 1,2-diarylindoles from readily available cyclohexanones, α-hydroxyketones and anilines.
Microbial transformation of 2-hydroxy and 2-acetoxy ketones with Geotrichum sp.
Wei, Zhi-Liang,Lin, Guo-Qiang,Li, Zu-Yi
, p. 1129 - 1137 (2007/10/03)
Biotransformation of a series of o-, m- and p-substituted α-hydroxy- and α-acetoxyphenylethanones 1a-h and 9a-g with Geotrichum sp. led to the corresponding 1,2-diols 2 and/or monoacetates 10 in moderate to excellent enantiomeric excesses. α-Hydroxy- and α-acetoxyphenylethanones and their m- and p-derivatives gave preponderantly the S-configuration products while in the case of the o-derivatives R-alcohol was provided as the major enantiomer. The results of stereoselectivity were discussed. (C) 2000 Elsevier Science Ltd.
Antisecretory guanidine derivatives and pharmaceutical compositions containing them
-
, (2008/06/13)
The guanidine derivative has the formula: STR1 where X is O or S: Y is N, CH or CCH3 : m is 0 or 1: R1 is hydrogen and R2 cyano, trifluoroacetyl, C1-6 alkanoyl, 4,5-dihydro-4-oxothiazol-2-yl or A-B where A is 3,4-dioxocyclobutene-1,2-diyl or C=Z where Z is oxygen, sulphur, NCN, NNO2, CHNO2, NCONH2, C(CN)2, NCOR6, NCO2 R6, NSO2 R6 or NR7 where R6 is C1-6 alkyl and R7 is hydrogen or C1-6 alkyl and B is C1-6 alkyl, alkoxy or alkylthio or NR8 R9 where R8 and R9 are hydrogen, C1-10 alkyl, C3-10 -alkenyl, alkynyl or alkoxyalkyl, C2-6 (primary hydroxy)alkyl, or, when R9 is hydrogen, R8 is 2-[[5-dimethylaminomethylfuran-2-yl]methylthio]-ethylamino or R8 and R9 are together a 5- or 6-membered non-aromatic ring optionally containing an additional N or O; or R1 and R2 are together imidazolidin-2-ylidene: R3 is hydrogen or fluorine: R4 is halogen or methyl: R5 is hydrogen, C1-6 alkyl or C3-10 alkoxyalkyl: and the salts thereof.